Ligand validation:3BS0

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 3BS0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3BS0_C8E_B_502	26%	18%	0.216	0.855	1.3	2.41	3	6	0	0	100%	0.7143
3BS0_C8E_A_501	18%	29%	0.238	0.822	0.93	2.04	-	6	1	0	100%	0.7143
3BS0_C8E_B_504	7%	23%	0.37	0.833	1.07	2.26	1	8	7	0	100%	1
3BS0_C8E_A_503	3%	20%	0.327	0.686	1.34	2.18	1	6	0	0	100%	1
3BRZ_C8E_A_501	1%	28%	0.683	0.784	0.94	2.08	-	6	8	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.41	1.08	-	2	3	0	100%	1
5MDO_C8E_B_404	61%	73%	0.118	0.908	0.36	0.65	-	-	0	0	100%	1
5DL7_C8E_A_506	61%	47%	0.123	0.912	0.72	1.34	-	3	4	0	100%	1
6HCP_C8E_C_824	59%	77%	0.116	0.924	0.46	0.46	-	-	1	0	86%	0.8571

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.